We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

18 hedge funds and large institutions have $51.2M invested in Tonix Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

20% more funds holding

Funds holding: 15 → 18 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

40% less capital invested

Capital invested by funds: $85.3M → $51.2M (-$34.1M)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.38M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.46M
3
BlackRock
BlackRock
New York
+$974K
4
State Street
State Street
Massachusetts
+$974K
5
Citadel Advisors
Citadel Advisors
Florida
+$487K

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$3.06M
2
Renaissance Technologies
Renaissance Technologies
New York
-$974K
3
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$487K
4
Millennium Management
Millennium Management
New York
-$487K
5
ECM
ExodusPoint Capital Management
New York
-$239K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$112K – – –
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$106K -$487K -1 Closed
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$106K – – –
VOYA Investment Management
29
VOYA Investment Management
Georgia
$78K – – –
EMG
30
ETF Managers Group
New Jersey
$72K – – –
Bank of America
31
Bank of America
North Carolina
$71K – – –
Invesco
32
Invesco
Georgia
$63K – – –
EDRH
33
Edmond de Rothschild Holding
Switzerland
$60K – – –
Principal Financial Group
34
Principal Financial Group
Iowa
$56K – – –
AQR Capital Management
35
AQR Capital Management
Connecticut
$54K – – –
Jane Street
36
Jane Street
New York
$48K – – –
SO
37
STRS Ohio
Ohio
$45K – – –
Two Sigma Advisers
38
Two Sigma Advisers
New York
$37K – – –
WG
39
Winton Group
United Kingdom
$37K – – –
Victory Capital Management
40
Victory Capital Management
Texas
$32K – – –
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$29K – – –
Citigroup
42
Citigroup
New York
$28K – – –
ProShare Advisors
43
ProShare Advisors
Maryland
$28K – – –
AB
44
Amalgamated Bank
New York
$27K – – –
RJFSA
45
Raymond James Financial Services Advisors
Florida
$22K – – –
MA
46
MONECO Advisors
Connecticut
$21K – – –
Osaic Holdings
47
Osaic Holdings
Arizona
$20K – – –
Legal & General Group
48
Legal & General Group
United Kingdom
$18K – – –
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$17K – – –
GPFA
50
Game Plan Financial Advisors
Ohio
$16K – – –
1
2
3 4

TNXP Hedge Fund Activity: Q3 2021 in Review

18 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q3 2021, worth a combined $51.2M — down 40% from $85.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TNXP positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $4.38M. The largest seller was Norges Bank, exiting entirely with an estimated $3.06M sold.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q3 2021, up from 15 in Q2 2021.
  • Funds reported $51.2M of Tonix Pharmaceuticals stock for Q3 2021, down 40% quarter-over-quarter.
  • 6 funds opened new Tonix Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q3 2021 was D.E. Shaw & Co, an estimated $4.38M added.
  • The largest Tonix Pharmaceuticals seller in Q3 2021 was Norges Bank, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2021.